DORA Regulatory Notice: Pharmacy – New and Multiple Revised Rules
Thursday, September 30 @ 8:45 am - 11:00 am
The Department of Regulatory Agencies – Pharmacy will be holding a rulemaking hearing on Thursday, September 30th, 2021, 8:45 am on rules regarding New and Multiple Revised Rules. The hearing will be held at: 1560 Broadway (See Hearing Notes), Denver CO 80202.
The purpose of this rulemaking is:
The purpose of this Permanent Rulemaking Hearing is for the Board to consider adopting new and revised rules to provide clarity and a general cleanup of the rules; and implement Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists); Colorado Senate Bill 21-077 (Concerning the elimination of verification of an individual’s lawful presence in the United States as a requirement for individual credentialing); Colorado Senate Bill 21-094 (Concerning the continuation of the State Board of Pharmacy, and implementing recommendations contained in the 2020 sunset report by the Department of Regulatory Agencies and making other changes regarding the practice of professions regulated by the Board); Colorado Senate Bill 21-098 (Concerning the continuation of the prescription drug monitoring program); Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists pursuant to a standing order); and Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program to include prescription drug suppliers from nations other than Canada upon the enactment of legislation by the United States congress authorizing such practice).
If you believe there will be a significant negative impact on small business, job creation or economic competitiveness, you may request that the Department of Regulatory Agencies require the rulemaking agency to prepare a cost-benefit analysis of a proposed rule or amendment. This request must be made to the Department of Regulatory Agencies by Wednesday, September 15th, 2021.
You may also submit comments directly to the rulemaking agency for the agency’s consideration during the upcoming rulemaking hearing
We hope this information is helpful to you. Thank you for taking the time to participate in the rulemaking process.
Due to concerns surrounding COVID-19, this Permanent Rulemaking Hearing will be held solely via webinar. Please register using the webinar link below.
Brian Tobias, Director
Colorado Office of Policy, Research and Regulatory Reform